Spire Wealth Management - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 296 filers reported holding HAEMONETICS CORP in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2023$1,655
+23542.9%
20
-76.2%
0.00%
Q4 2022$7
-100.0%
84
-85.2%
0.00%
-100.0%
Q3 2022$42,000
+13.5%
5690.0%0.00%
+50.0%
Q2 2022$37,000
+2.8%
5690.0%0.00%
+100.0%
Q1 2022$36,000
+20.0%
569
-1.0%
0.00%0.0%
Q4 2021$30,000
+900.0%
575
+1953.6%
0.00%
Q1 2021$3,000280.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders